Angiotensin converting enzyme inhibitor - Medicow
About us  |  Why use us?  |  Press  |  Contact us

 

Topic: Angiotensin converting enzyme inhibitor


  
 MedlinePlus Drug Information: Angiotensin-converting Enzyme (ACE) Inhibitors (Systemic)
Liver disease—ACE inhibitors' effects may be increased because of slower removal of medicine from the body
ACE inhibitors belong to the class of medicines called high blood pressure medicines (antihypertensives).
Previous reaction to any ACE inhibitor or previous occurrence involving hoarseness; swelling of face, mouth, hands, or feet; or sudden trouble in breathing—Reaction is more likely to occur again
http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202044.html   (3229 words)

  
 Angiotensin-converting enzyme (ACE) inhibitors for coronary artery disease - [Medication]
ACE inhibitors help lower blood pressure and reduce the workload on the heart, which lowers the chances of heart attack.
Also, if an ACE inhibitor is not already used, it is usually prescribed immediately after a heart attack.
Use of ACE inhibitors following a heart attack can also help prevent the development of heart failure related to a heart attack.
http://www.peacehealth.org/kbase/topic/detail/drug/hw100755/detail.htm   (541 words)

  
 Angiotensin-converting enzyme (ACE) inhibitors - [Medication]
ACE inhibitors, rather than ARBs, continue to be the medication of choice for heart failure.
ACE inhibitors are the drugs of choice for treating heart failure.
ACE inhibitors affect the body's responses to heart failure.
http://www.peacehealth.org/kbase/topic/detail/drug/aa86713/detail.htm   (611 words)

  
 Merck Vet. Edition - Angiotensin-converting Enzyme Inhibitors
The approved use of enalapril in dogs is as adjunctive therapy with furosemide and digoxin for dilated cardiomyopathy, or with furosemide with or without digoxin for chronic valvular insufficiency.
Angiotensin-converting enzyme (ACE) inhibitors are widely used in treating chronic congestive heart failure (CHF) in dogs.
Relative to other drugs used to treat CHF, ACE inhibitors have a better safety profile.
http://www.merckvetmanual.com/mvm/htm/bc/190206.htm   (594 words)

  
 Angiotensin-converting enzyme inhibitors
Anyone who takes ACE inhibitors should let the physician know all other medicines he or she is taking and should ask about foods that should be avoided.
Taking ACE inhibitors with certain other drugs may affect the way the drugs work or may increase the chance of side effects.
ACE inhibitors may interact with certain foods and other medicines.
http://www.healthatoz.com/healthatoz/Atoz/ency/angiotensin-converting_enzyme_inhibitors.jsp   (1607 words)

  
 Angiotensin-Converting Enzyme Inhibitors -- Brown and Vaughan 97 (14): 1411 -- Circulation
Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy.
therapeutic or adverse effects of ACE inhibitors is uncertain.
Although ACE inhibitors improve outcome in patients with systolic
http://circ.ahajournals.org/cgi/content/full/97/14/1411   (6721 words)

  
 Texas Medicaid Vendor Drug, Criteria - Angiotension-Converting Enzyme(ACE)
Chronic ACE inhibitor therapy may potentiate the release of endogenous vasodilating prostaglandins.
Additional therapeutic benefit is not realized when ACE inhibitors are used in combination.
Patient profiles will be assessed to identify those drug regimens which may result in clinically significant drug-drug interactions.
http://www.hhsc.state.tx.us/HCF/vdp/Criteria/ace.html   (879 words)

  
 North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary ...
Only 20-30% of patients assessed by their general practitioner as having heart failure are prescribed an angiotensin converting
to guide general practitioners in their use of angiotensin
Heart failure is a common condition in general practice and has a poor prognosis
http://bmj.bmjjournals.com/cgi/content/full/316/7141/1369   (4838 words)

  
 Angiotensin II Receptor Blockers
ACE inhibitors also decrease bradykinin breakdown and this action could be involved in some of the beneficial and adverse effects of that class of drugs.
However, non-ACE pathways can produce some angiotensin II.
Most likely these 3 trials reflect worse outcomes with dihydropyridine CCBs, consistent with previous evidence (
http://www.ti.ubc.ca/pages/letter28.htm   (1890 words)

  
 Current Controlled Trials in Cardiovascular Medicine Full text How long should angiotensin-converting enzyme ...
This is an issue that needs to be addressed when considering optimal treatment of patients after a myocardial infarction.
A literal interpretation of the results of the HOPE trial would suggest that all patients following myocardial infarction should be placed on ACE inhibitors.
Yusuf S: Clinical, public health, and research implications of the Heart Outcomes Prevention Evaluation (HOPE) Study.
http://cvm.controlled-trials.com/content/2/4/151   (2832 words)

  
 Angiotensin-Converting Enzyme (ACE) Inhibitors, ACE Inhibitors, Aceon, Cilazapril, Fosinopril, Mavik, Monopril, ...
Therefore, individuals should consult their healthcare practitioner before supplementing additional potassium and should have their blood levels of potassium checked periodically while taking ACE inhibitors.
Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.
For interactions involving specific ACE inhibitors, refer to the highlighted drugs listed below.
http://www.truestarhealth.com/Notes/1070000.html   (659 words)

  
 Angiotensin-Converting Enzyme Inhibitors after Acute Myocardial Infarction -- Pilote and Abrahamowicz 142 (1): 78 -- ...
other ACE inhibitors in our study were large compared with those
Jorde refers to an unpublished study that investigates outcomes
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.
http://www.annals.org/cgi/content/full/142/1/78-b   (670 words)

  
 News - Potential Use of Statins and Angiotensin-Converting Enzyme Inhibitors to Treat Cardiac Syndrome X
SX is characterised by chest pain with normal angiogram results, and is associated with high morbidity.
The authors conclude that the "6 months of therapy with atorvastatin and ramipril improves endothelial function and quality of life of patients with SX."
Antioxidant therapy using a statin/angiotensin-converting enzyme inhibitor (ACE-I) combination effectively improves endothelial function and quality of life in patients with cardiac syndrome X (SX), according to a randomised, prospective study.
http://www.docguide.com/news/content.nsf/news/8525697700573E1885256E0E00388CB9   (508 words)

  
 Arch Intern Med -- Abstract: Hyperkalemia in Outpatients Using Angiotensin-Converting Enzyme Inhibitors: How Much ...
Renal Considerations in Angiotensin Converting Enzyme Inhibitor Therapy: A Statement for Healthcare Professionals From the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association
variables included changes in therapy with ACE inhibitor, maximum
Results  Of 1818 patients using ACE inhibitors, 194 (11%)
http://archinte.ama-assn.org/cgi/content/abstract/158/1/26   (422 words)

  
 Review: angiotensin-converting enzyme inhibitors reduce the progression of non-diabetic renal disease -- Berns 7 (1): ...
Sentiment is growing that ACE inhibitors should be the drugs
be concluded that ACE inhibitors were more effective than other
11 studies (1860 patients; 941 in the ACE inhibitor group and
http://ebm.bmjjournals.com/cgi/content/full/7/1/13   (576 words)

  
 NEJM -- Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive ...
Doughty, R.N., Sharpe, N. Optimization of ACE inhibitor therapy in heart failure.
Outcomes of Acute Exacerbation of Severe Congestive Heart Failure: Quality of Life, Resource Use, and Survival.
Roffman, D. High-Versus Low-Dose ACE Inhibitor Therapy in Chronic Heart Failure.
http://content.nejm.org/cgi/content/abstract/325/5/293   (8726 words)

  
 Angiotensin-Converting Enzyme Inhibitors
This evidence-based clinical practice guideline is produced by the North of England Evidence Based Guideline Development Project at the Centre for Health Services Research, University of Newcastle upon Tyne.
Evidence based clinical practice guideline : ACE inhibitors for heart failure
The aim of this guideline is to aid in the management of heart failure in primary care by providing recommendations on the appropriate use of ACE inhibitors as treatment.
http://www.omni.ac.uk/browse/mesh/D000806.html   (96 words)

  
 Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria (Cochrane Review)
One further study met all conditions for inclusion but did not provide data in useable form for meta-analyses.
Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.
Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria (Cochrane Review)
http://www.cochrane.org/cochrane/revabstr/ab002183.htm   (486 words)

  
 Angiotensin-converting enzyme (ACE) inhibitors - MayoClinic.com
Find out more about this class of medication.
Which one is best for you depends on your health and the condition being treated.
ACE inhibitors treat a variety of conditions, such as high blood pressure, scleroderma and migraines.
http://www.mayoclinic.com/health/ace-inhibitors/HI00060   (347 words)

  
 Cardiovascular Effects of Fermented Milk Containing Angiotensin-Converting Enzyme Inhibitors Evaluated in Permanently ...
The enzyme is also responsible for the breakdown
that does not produce inhibitors were used as controls.
Since the inhibitors formed are peptides, which are formed by
http://aem.asm.org/cgi/content/full/68/7/3566   (2773 words)

  
 NEJM -- Outcomes of Reference Pricing for Angiotensin-Converting-Enzyme Inhibitors
percent of patients who had been prescribed ACE inhibitors subject
for ACE inhibitors was introduced in British Columbia, patients
(ACE) inhibitors for patients 65 years of age or older was introduced
http://content.nejm.org/cgi/content/abstract/346/11/822   (800 words)

  
 Impact of Angiotensin-Converting Enzyme Inhibitors and Statins on Survival in Idiopathic Pulmonary Fibrosis -- Nadrous ...
Study objectives: To assess the clinical relevance of angiotensin-converting
Tan, A, Levrey, H, Dahm, C, et al Lovastatin induces fibroblast apoptosis in vitro and in vivo: a possible therapy for fibroproliferative disorders.
Idiopathic pulmonary fibrosis (IPF) is a chronic, diffuse, parenchymal
http://www.chestjournal.org/cgi/content/full/126/2/438   (3494 words)

  
 ASN: Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Safe in Early Post-Transplant Period
Sixteen patients with hypertension were treated with an ACE inhibitor or ARB (cases).
Creatinine and potassium were similar for the first nine months in hypertensive renal transplant patients treated with an ACE inhibitor or ARB versus controls who took a calcium channel blocker.
There were no significant differences between creatinine, potassium and haemoglobin values between case and control patients, except at Month 1 for haemoglobin, when the value was 12.3 g/L for cases and 10.9 g/L for controls (p=0.01).
http://www.pslgroup.com/dg/221EB6.htm   (428 words)

  
 IV. ANGIOTENSIN CONVERTING ENZYME INHIBITORS The angiotensin converting enzyme (ACE) inhib
The 2 avail- able drugs in this group are very similar in their effects and may be discussed together.
ANGIOTENSIN CONVERTING ENZYME INHIBITORS The angiotensin converting enzyme (ACE) inhibitors are effective antihypertensive agents and have other indications as well.
The major difference between them is that captopril is an active drug with a shorter duration of action 8-12 hours) while enalapril is a prodrug that must be metabolized to the active form, enalaprilat, which has a longer duration of action (12-24 hours).
http://www.skepticfiles.org/md001/aceinhib.htm   (437 words)

  
 News - High Doses of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Required for Maximum ...
The results from such studies have led the American Diabetes Association to recommend ARBs as the treatment of choice for patients with type 2 diabetes and diabetic nephropathy, and ARBs or ACEIs for patients with microalbuminuria.
For example, one study using ACE inhibitor/ARB combination therapy revealed a greater reduction in proteinuria for subjects on a low-sodium diet compared to those on a high sodium diet.
To examine the optimal dosages of ACE inhibitors and ARBs, Marc S. Weinberg, MD, Rush Presbyterian/St Luke's Medical Center, Chicago, Illinois, United States, and colleagues reviewed several comparative studies in diabetic subjects that evaluated the effect of usual or high doses of RAS blockers as monotherapy or combination therapy.
http://www.docguide.com/news/content.nsf/news/8525697700573E1885256D96003111C6   (626 words)

  
 Review: angiotensin converting enzyme inhibitors are beneficial in type 1 diabetes mellitus and microalbuminuria ...
This meta-analysis aggregated individual patient data from each
recommend the use of ACE inhibitors for patients with type 1
systemic blood pressure from ACE inhibitors explains some, but
http://ebm.bmjjournals.com/cgi/content/full/6/5/146   (622 words)

  
 Angiotensin Converting Enzyme (ACE) Inhibitors, Cincinnati Children's Hospital Medical Center
This vasodilation helps the heart function in many patients by decreasing how hard the ventricle has to squeeze to eject blood.
ACE inhibitors cause dilation of the arterial system, not always associated with a lowering of the blood pressure.
ACE inhibitors are now the second most common class used in congestive heart failure in children.
http://www.cincinnatichildrens.org/health/info/heart/medication/ace.htm   (126 words)

  
 Role of Angiotensin-Converting Enzyme Inhibitors in the Coronary Artery Bypass Patient -- Lazar 79 (3): 1081 -- The ...
Role of Angiotensin-Converting Enzyme Inhibitors in the Coronary Artery Bypass Patient -- Lazar 79 (3): 1081 -- The Annals of Thoracic Surgery
Role of Angiotensin-Converting Enzyme Inhibitors in the Coronary Artery Bypass Patient
http://ats.ctsnetjournals.org/cgi/content/abstract/79/3/1081   (120 words)

  
 Energy Citations Database (ECD) - Energy and Energy-Related Bibliographic Citations
Availability information may be found in the Availability, Publisher, Research Organization, Resource Relation and/or Author (affiliation information) fields and/or via the "Full-text Availability" link.
Angiotensin-converting enzyme inhibitors: measurement of relative inhibitory potency and serum drug levels by radioinhibitor binding displacement assay
550201 -- Biochemistry-- Tracer Techniques; ENZYME INHIBITORS-- BIOCHEMICAL REACTION KINETICS;ENZYME INHIBITORS-- RADIOENZYMATIC ASSAY; DOSE-RESPONSE RELATIONSHIPS;IODINE 125;LIGANDS;TRACER TECHNIQUES
http://www.osti.gov/energycitations/product.biblio.jsp?osti_id=6125719   (123 words)

  
 Find in a Library: Angiotensin-converting enzyme inhibitors
Subjects: Angiotensin converting enzyme -- Inhibitors -- Therapeutic use.
To find a library, type in a postal code, state, province, or country.
WorldCat is provided by OCLC Online Computer Library Center, Inc. on behalf of its member libraries.
http://worldcatlibraries.org/wcpa/ow/fbea23e4cc18dd3ea19afeb4da09e526.html   (38 words)

  
 Angiotensin converting enzyme inhibitors information Diseases Database
Angiotensin converting enzyme inhibitors to medical search engines.
Content is not asserted complete or error free, please see also our disclaimer.
If your browser has no JavaScript you can still use these:
http://www.diseasesdatabase.com/ddb29568.htm   (82 words)

 About us   |  Why use us?   |  Press   |  Contact us

 Copyright © 2006 Medicow.com Usage implies agreement with terms.